| Nathan Edward Tobey, MD | |
|
3344 N Futrall Dr, Fayetteville, AR 72703 | |
| (479) 521-8200 | |
| (479) 582-7329 |
| Full Name | Nathan Edward Tobey |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 11 Years |
| Location | 3344 N Futrall Dr, Fayetteville, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306188479 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Washington Regional Medical Center | Fayetteville, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Associates Of Northwest Arkansas, Pa | 3678542073 | 98 |
News Archive
Advanced Cell Technology, Inc. announced today that it has strengthened its balance sheet through the elimination of approximately $3 million in debt over the past several weeks. The conversion of senior and subordinated debentures to equity has reduced the Company's outstanding convertible debentures to approximately $890,000. Since September 2009, Advanced Cell has eliminated approximately $33 million in indebtedness.
Researchers can now reconstruct what we see in our minds when we navigate - and explain how we get directions wrong.
A relatively simple and inexpensive method may be used to determine whether a lung cancer patient is a candidate for crizotinib therapy, according to research published in the August issue of the Journal of Thoracic Oncology, the official monthly journal of the International Association for the Study of Lung Cancer.
A new study suggests that despite considerable adversity, many people have also experienced positive effects in lockdown as a result of a less frenetic life.
The eyesight of thousands of people in the UK will be saved with a new drug available under the National Health Service.
› Verified 7 days ago
| Entity Name | Medical Associates Of Northwest Arkansas, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801847827 PECOS PAC ID: 3678542073 Enrollment ID: O20041001000671 |
News Archive
Advanced Cell Technology, Inc. announced today that it has strengthened its balance sheet through the elimination of approximately $3 million in debt over the past several weeks. The conversion of senior and subordinated debentures to equity has reduced the Company's outstanding convertible debentures to approximately $890,000. Since September 2009, Advanced Cell has eliminated approximately $33 million in indebtedness.
Researchers can now reconstruct what we see in our minds when we navigate - and explain how we get directions wrong.
A relatively simple and inexpensive method may be used to determine whether a lung cancer patient is a candidate for crizotinib therapy, according to research published in the August issue of the Journal of Thoracic Oncology, the official monthly journal of the International Association for the Study of Lung Cancer.
A new study suggests that despite considerable adversity, many people have also experienced positive effects in lockdown as a result of a less frenetic life.
The eyesight of thousands of people in the UK will be saved with a new drug available under the National Health Service.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nathan Edward Tobey, MD Po Box 1523, Fayetteville, AR 72702-1523 Ph: (479) 571-6038 | Nathan Edward Tobey, MD 3344 N Futrall Dr, Fayetteville, AR 72703 Ph: (479) 521-8200 |
News Archive
Advanced Cell Technology, Inc. announced today that it has strengthened its balance sheet through the elimination of approximately $3 million in debt over the past several weeks. The conversion of senior and subordinated debentures to equity has reduced the Company's outstanding convertible debentures to approximately $890,000. Since September 2009, Advanced Cell has eliminated approximately $33 million in indebtedness.
Researchers can now reconstruct what we see in our minds when we navigate - and explain how we get directions wrong.
A relatively simple and inexpensive method may be used to determine whether a lung cancer patient is a candidate for crizotinib therapy, according to research published in the August issue of the Journal of Thoracic Oncology, the official monthly journal of the International Association for the Study of Lung Cancer.
A new study suggests that despite considerable adversity, many people have also experienced positive effects in lockdown as a result of a less frenetic life.
The eyesight of thousands of people in the UK will be saved with a new drug available under the National Health Service.
› Verified 7 days ago
Lauren Cantwell Paulk, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1706 E Joyce Blvd Ste 2, Fayetteville, AR 72703 Phone: 479-966-9370 | |
David R Crittenden, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1408 E Elmwood Dr, Fayetteville, AR 72703 Phone: 479-442-0759 | |
Kim R Agee, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 3344 N Futrall Dr, Fayetteville, AR 72703 Phone: 479-521-8200 Fax: 479-582-7310 | |
Dr. David A Churchill, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3211 N Northhills Blvd, Suite 110, Fayetteville, AR 72703 Phone: 479-571-4338 Fax: 479-571-4015 | |
Dr. Marlan Levan Rhame Iii, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1100 N College Ave, Fayetteville, AR 72703 Phone: 479-443-4301 Fax: 479-587-5929 | |
Waqar M Mehal, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 12 E Appleby, Suite 101, Fayetteville, AR 72703 Phone: 479-463-4444 Fax: 479-463-4499 | |
Dr. Juan I Lombeida, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3232 N North Hills Blvd, Fayetteville, AR 72703 Phone: 479-587-1700 |